GSK Begins $450M 2nd Round Of Share-Buyback Program
GSK launched a share repurchasing program worth up to £450 million ($609 million) on Wednesday, part of the pharmaceutical company's ongoing plan to return excess cash to its shareholders....To view the full article, register now.
Already a subscriber? Click here to view full article